Taste dysfunction in multiple sclerosis.
Doty RL, Tourbier IA, Pham DL, Cuzzocreo JL, Udupa JK, Karacali B, Beals E, Fabius L, Leon-Sarmiento FE, Moonis G, Kim T, Mihama T, Geckle RJ, Yousem DM.
J Neurol. 2016 Apr;263(4):677-88. doi: 10.1007/s00415-016-8030-6. Epub 2016 Jan 25.
Incidental Lesions Suggesting Multiple Sclerosis.
Okuda DT.
Continuum (Minneap Minn). 2016 Jun;22(3):730-43. doi: 10.1212/CON.0000000000000339.
QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions.
Gillen KM, Mubarak M, Park C, Ponath G, Zhang S, Dimov A, Levine-Ritterman M, Toro S, Huang W, Amici S, Kaunzner UW, Gauthier SA, Guerau-de-Arellano M, Wang Y, Nguyen TD, Pitt D.
Ann Clin Transl Neurol. 2021 Apr;8(4):877-886. doi: 10.1002/acn3.51338. Epub 2021 Mar 11.
Magnetic resonance susceptibility weighted imaging in neurosurgery: current applications and future perspectives.
Di Ieva A, Lam T, Alcaide-Leon P, Bharatha A, Montanera W, Cusimano MD.
J Neurosurg. 2015 Dec;123(6):1463-75. doi: 10.3171/2015.1.JNS142349. Epub 2015 Jul 24.
Iron deposits in multiple sclerosis and Alzheimer's disease brains.
LeVine SM.
Brain Res. 1997 Jun 20;760(1-2):298-303. doi: 10.1016/s0006-8993(97)00470-8.
Neuro-Behcet's syndrome: Case report and literature review.
Peine B, Figueroa C, Robinette N.
Radiol Case Rep. 2022 Jun 21;17(9):3064-3070. doi: 10.1016/j.radcr.2022.05.070. eCollection 2022 Sep.
Management approach including pembrolizumab for fingolimod-associated progressive multifocal leukoencephalopathy in a patient with relapsing-remitting multiple sclerosis.
Barritt AW, Das E, Morley N, Seymour M, Saha R, Vera J, Vundavalli S, Dizdarevic S, Nicholas R, Berger JR, Fisniku LK.
Mult Scler. 2023 Feb;29(2):301-306. doi: 10.1177/13524585221137279. Epub 2022 Nov 30.
Brain magnetic resonance imaging helps to differentiate atypical multiple sclerosis with cavitary lesions and vanishing white matter disease.
Ayrignac X, Menjot de Champfleur N, Menjot de Champfleur S, Carra-Dallière C, Deverdun J, Corlobe A, Labauge P.
Eur J Neurol. 2016 Jun;23(6):995-1000. doi: 10.1111/ene.12931. Epub 2016 Jan 4.
Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome.
Merrill JE.
J Immunother (1991). 1992 Oct;12(3):167-70. doi: 10.1097/00002371-199210000-00004.
Magnetic resonance imaging changes following natalizumab discontinuation in multiple sclerosis patients with progressive multifocal leukoencephalopathy.
Hodel J, Bapst B, Outteryck O, Verclytte S, Deramecourt V, Benadjaoud MA, Pruvo JP, Vermersch P, Leclerc X.
Mult Scler. 2018 Dec;24(14):1902-1908. doi: 10.1177/1352458517750765. Epub 2018 Jan 18.
